Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Dobronravov

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Terapevticheskii Arkhiv|July 20, 2000
[Risk of chronic renal failure in patients with non-insulin dependent diabetes mellitus with diabetic nephropathy and the stage of permanent proteinuria and arterial hypertension: role of clinical factors]V A Dobronravov
Klinicheskaia Meditsina|January 1, 1996
[Factors predicting chronic renal failure in membranoproliferative glomerulonephritis]V A Dobronravov
Terapevticheskii Arkhiv|January 1, 1994
[The progression rates of different morphological forms of chronic glomerulonephritis in the pre-azotemia period (is the morphological form of chronic glomerulonephritis the factor that determines the prognosis?)]S I Riabov, V A Dobronravov
Terapevticheskii Arkhiv|February 1, 2019
Membranoproliferative glomerulonephritis in Russian populationV A Dobronravov, A V Smirnov
Terapevticheskii Arkhiv|October 26, 2022
[Remissions and progression of C3 glomerulopathy]A V Karunnaya, V A Dobronravov
Terapevticheskii Arkhiv|July 27, 2017
[Nephrological aspects of complement-mediated thrombotic microangiopathy]A V Smirnov, A V Karunnaya, V A Dobronravov
Terapevticheskii Arkhiv|August 25, 2010
[Phosphorus and calcium metabolism and the cardiovascular system status in patients with early-stage chronic renal disease]A V Smirnov, M M Volkov, V A Dobronravov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[A novel approach to rapid induction of remission in primary membranous nephropathy]V A Dobronravov, O B Bystrova, Z S Kochoyan, et al.
Terapevticheskii Arkhiv|August 6, 2024
[Immunosuppression, tonsillectomy and remissions in high-risk IgA-nephropathy]Z S Kochoyan, A Z Lieva, T O Galkovskaya, et al.
Terapevticheskii Arkhiv|December 21, 2020
[The analysis of treatment of Immunoglobulin A-nephropathy]V A Dobronravov, Z S Kochoyan, T O Muzhetskaya, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Terapevticheskii Arkhiv|July 20, 2000
[Risk of chronic renal failure in patients with non-insulin dependent diabetes mellitus with diabetic nephropathy and the stage of permanent proteinuria and arterial hypertension: role of clinical factors]V A Dobronravov
Klinicheskaia Meditsina|January 1, 1996
[Factors predicting chronic renal failure in membranoproliferative glomerulonephritis]V A Dobronravov
Terapevticheskii Arkhiv|January 1, 1994
[The progression rates of different morphological forms of chronic glomerulonephritis in the pre-azotemia period (is the morphological form of chronic glomerulonephritis the factor that determines the prognosis?)]S I Riabov, V A Dobronravov
Terapevticheskii Arkhiv|February 1, 2019
Membranoproliferative glomerulonephritis in Russian populationV A Dobronravov, A V Smirnov
Terapevticheskii Arkhiv|October 26, 2022
[Remissions and progression of C3 glomerulopathy]A V Karunnaya, V A Dobronravov
Terapevticheskii Arkhiv|July 27, 2017
[Nephrological aspects of complement-mediated thrombotic microangiopathy]A V Smirnov, A V Karunnaya, V A Dobronravov
Terapevticheskii Arkhiv|August 25, 2010
[Phosphorus and calcium metabolism and the cardiovascular system status in patients with early-stage chronic renal disease]A V Smirnov, M M Volkov, V A Dobronravov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[A novel approach to rapid induction of remission in primary membranous nephropathy]V A Dobronravov, O B Bystrova, Z S Kochoyan, et al.
Terapevticheskii Arkhiv|August 6, 2024
[Immunosuppression, tonsillectomy and remissions in high-risk IgA-nephropathy]Z S Kochoyan, A Z Lieva, T O Galkovskaya, et al.
Terapevticheskii Arkhiv|December 21, 2020
[The analysis of treatment of Immunoglobulin A-nephropathy]V A Dobronravov, Z S Kochoyan, T O Muzhetskaya, et al.
Pageof 3